Related Experiment Video
Updated: Dec 16, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event
Shirley V Wang1, Kristina Stefanini2, Edwin Lewis3
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA. swang1@bwh.harvard.edu.
Insights
This study introduces a systematic method to identify which vaccine, among multiple given simultaneously, may cause adverse events like seizures. The process successfully pinpointed diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) vaccines as potential seizure triggers.
Area of Science:
- Vaccinology
- Epidemiology
- Biostatistics
Background:
- Childhood immunization schedules often involve administering multiple vaccines during a single visit.
- Identifying the specific vaccine responsible for an adverse event following simultaneous vaccination can be challenging.
Purpose of the Study:
- To develop and illustrate a systematic process for determining which vaccine(s) administered on the same day are most likely to cause an observed increase in adverse event risk.
- To apply this method to identify potential triggers for seizures post-vaccination.
Main Methods:
- Utilized a simulation approach based on an empirical cohort of vaccinated children with observed simultaneous vaccination patterns.
- Simulated independent and interactive effects of diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) vaccines on seizure risk.
- Applied the systematic identification process to simulated data and subsequently to empirical data.
Main Results:
- The systematic process successfully identified contributing vaccines in all simulations.
- In empirical data, the risk of seizure was narrowed down to DTaP, PCV, and/or Haemophilus influenzae type B (HiB) vaccines (attributable risk: 5 per 100,000 when all three were given).
- No excess risk of seizure was observed when these three specific vaccines were not administered.
Conclusions:
- The outlined process can provide valuable insights into the risks associated with individual and simultaneous vaccinations.
- Further investigation using independent data and biologically based hypotheses is recommended to confirm associations.
Introduction:
Childhood immunization schedules often involve multiple vaccinations per visit. When increased risk of an adverse event is observed after simultaneous (same-day) vaccinations, it can be difficult to ascertain which triggered the adverse event. This methods paper discusses a systematic process to determine which of the simultaneously administered vaccine(s) are most likely to have caused an observed increase in risk of an adverse event.
Methods:
We use an example from the literature where excess risk of seizure was observed 1 day after vaccination, but same-day vaccination patterns made it difficult to discern which vaccine(s) may trigger the adverse event. We illustrate the systematic identification process using a simulation that retained the observed pattern of simultaneous vaccination in an empirical cohort of vaccinated children. We simulated "true" effects for diphtheria-tetanus-acellular pertussis (DTaP) and pneumococcal conjugate (PCV) on risk of seizure the day after vaccination. We varied the independent and interactive effects of vaccines (on the multiplicative scale). After applying the process to simulated data, we evaluated risk of seizure 1 day after vaccination in the empirical cohort.
Results:
In all simulations, we were able to determine which vaccines contributed to excess risk. In the empirical data, we narrowed the association with seizure from all vaccines in the schedule to three likely candidates, DTaP, PCV, and/or Haemophilus influenzae type B (HiB) (p < 0.01, attributable risk when all three were administered together: five per 100,000). Disentangling their associations with seizure would require a larger sample or more variation in the combinations administered. When none of these three were administered, no excess risk was observed.
Conclusion:
The process outlined could provide valuable information on the magnitude of potential risk from individual and simultaneousvaccinations. Associations should be further investigated with independent data as well as biologically based, statistically independent hypotheses.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Vaccinations
Cross-reactivity
Dosage Interval and Administration Route: Determination Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

